These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 1971582)

  • 1. Relative contribution of the gut, liver, and lung to the first-pass hydrolysis (bioactivation) of orally administered 14C-fosinopril sodium in dogs. In vivo and in vitro studies.
    Morrison RA; Singhvi SM; Peterson AE; Pocetti DA; Migdalof BH
    Drug Metab Dispos; 1990; 18(2):253-7. PubMed ID: 1971582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sites of first-pass bioactivation (hydrolysis) of orally administered zofenopril calcium in dogs.
    Morrison RA; Burkett DE; Arnold ME; D'Arienzo CJ; Weinstein SH
    Pharm Res; 1991 Mar; 8(3):370-5. PubMed ID: 2052527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First pass metabolism and in vitro metabolism of a new orally active dopamine prodrug, N-(N-acetyl-L-methionyl)-O,O-bis(ethoxycarbonyl)dopamine in dogs.
    Yoshikawa M; Nishiyama S; Endo H; Togo Y; Takaiti O
    Drug Metab Dispos; 1991; 19(5):960-5. PubMed ID: 1686243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the liver and gut in systemic diphenhydramine clearance in adult nonpregnant sheep.
    Kumar S; Riggs KW; Rurak DW
    Drug Metab Dispos; 1999 Feb; 27(2):297-302. PubMed ID: 9929519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disposition of fosinopril sodium in healthy subjects.
    Singhvi SM; Duchin KL; Morrison RA; Willard DA; Everett DW; Frantz M
    Br J Clin Pharmacol; 1988 Jan; 25(1):9-15. PubMed ID: 2967089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of gut contents, intestinal wall, and liver on the first pass metabolism and absolute bioavailability of isotretinoin in the dog.
    Cotler S; Buggé CJ; Colburn WA
    Drug Metab Dispos; 1983; 11(5):458-62. PubMed ID: 6138231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the first-pass metabolism of ebastine in rats.
    Fujii T; Matsumoto S; Hatoyama T; Miyazaki H
    Arzneimittelforschung; 1997 Aug; 47(8):949-53. PubMed ID: 9296281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo evaluations of the metabolism, pharmacokinetics, and bioavailability of ester prodrugs of L-767,679, a potent fibrinogen receptor antagonist: an approach for the selection of a prodrug candidate.
    Prueksaritanont T; Gorham LM; Breslin MJ; Hutchinson JH; Hartman GD; Vyas KP; Baillie TA
    Drug Metab Dispos; 1997 Aug; 25(8):978-84. PubMed ID: 9280406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fosinopril, a phosphinic acid inhibitor of angiotensin I converting enzyme: in vitro and preclinical in vivo pharmacology.
    DeForrest JM; Waldron TL; Harvey C; Scalese B; Rubin B; Powell JR; Petrillo EW; Cushman DW
    J Cardiovasc Pharmacol; 1989 Nov; 14(5):730-6. PubMed ID: 2481187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Species and organ differences in first-pass metabolism of the ester prodrug L-751,164 in dogs and monkeys. In vivo and in vitro studies.
    Prueksaritanont T; Gorham LM; Ellis JD; Fernandez-Metzler C; Deluna P; Gehret JR; Strong KL; Hochman JH; Askew BC; Duggan ME; Gilbert JD; Lin JH; Vyas KP
    Drug Metab Dispos; 1996 Nov; 24(11):1263-71. PubMed ID: 8937862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism and disposition of trifluoperazine in the rat. II. Kinetics after oral and intravenous administration in acutely and chronically treated animals.
    Schmalzing G
    Drug Metab Dispos; 1977; 5(2):104-15. PubMed ID: 15802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for the involvement of a pulmonary first-pass effect via carboxylesterase in the disposition of a propranolol ester derivative after intravenous administration.
    Imai T; Yoshigae Y; Hosokawa M; Chiba K; Otagiri M
    J Pharmacol Exp Ther; 2003 Dec; 307(3):1234-42. PubMed ID: 14534358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution of the dipeptide transporter system along the gastrointestinal tract of rats based on absorption of a stable and specific probe, SQ-29852.
    Marino AM; Chong S; Dando SA; Kripalani KJ; Bathala MS; Morrison RA
    J Pharm Sci; 1996 Mar; 85(3):282-6. PubMed ID: 8699329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between metabolism and pharmacologic activity of SQ 27,786, an angiotensin converting enzyme inhibitor with potent diuretic activity.
    Everett DW; Singhvi SM; DeForrest JM; Morrison RA; Weinstein SH; Migdalof BH
    Drug Des Deliv; 1987 Sep; 2(1):23-34. PubMed ID: 3509342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uptake of N-[1 (S)-carboxy-(4-OH-3-125I-phenyl)ethyl]-L-Ala-L-Pro, an inhibitor of angiotensin-converting enzyme by rabbit lungs in situ.
    Turrin M; Pitt BR; Ryan JW; Chung AY; Clark MB; Gillis CN
    J Pharmacol Exp Ther; 1986 Jul; 238(1):14-8. PubMed ID: 3014113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First-pass disposition of (-)-6-aminocarbovir in rats. I. Prodrug activation may be limited by access to enzyme.
    Wen Y; Remmel RP; Zimmerman CL
    Drug Metab Dispos; 1999 Jan; 27(1):113-21. PubMed ID: 9884319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A radioimmunoassay for SQ 27,519, the active phosphinic acid-carboxylic diacid of the prodrug fosinopril in human serum.
    Tu JI; Brennan J; Stouffer B; Eckelman WC
    Ther Drug Monit; 1990 Jul; 12(4):404-10. PubMed ID: 2144379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Species differences in the pharmacokinetics and metabolism of indinavir, a potent human immunodeficiency virus protease inhibitor.
    Lin JH; Chiba M; Balani SK; Chen IW; Kwei GY; Vastag KJ; Nishime JA
    Drug Metab Dispos; 1996 Oct; 24(10):1111-20. PubMed ID: 8894513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central nervous and systemic kinetics of ramipril and ramiprilat in the conscious dog.
    Nordström M; Abrahamsson T; Ervik M; Forshult E; Regårdh CG
    J Pharmacol Exp Ther; 1993 Jul; 266(1):147-52. PubMed ID: 8331554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.